Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US
source: pixabay.com

Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US

   CRISPR is a gene-editing technique that has revolutionized the medical world with its approach to making precise changes in DNA. CRISPR found its match in 35-year-old Victoria Gray of…

Continue Reading Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US
PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome
Source: Pixabay

PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome

  According to a recent article, PharmaTher Holdings Ltd. announces the FDA granted orphan drug designation (ODD) for ketamine in the treatment of complex regional pain syndrome (CRPS). Complex Regional…

Continue Reading PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome